DDW Editor Reece Armstrong provides a sponsored interview with Rob Brown, PhD, Head of the scientific office at Sapio Sciences. Electronic lab notebooks (ELNs) have served as essential tools in researchers’ arsenals for decades. But as technology has advanced and the demands of drug discovery and development have… Read More
By Reece Armstrong Artificial intelligence is no longer just a vision for drug discovery — it is becoming a practical tool in the laboratory and a driver of new ways of working. At the recent “Data & AI to Accelerate Drug Discovery” summit, co-hosted by CAS, a division… Read More
Merck is expanding access to TEDDY (Transformers for Enabling Drug DiscoverY), its foundation model for drug discovery, by adding it to HuggingFace, the premier platform for open-source machine learning and LLMs. TEDDY was created in partnership with the Boston Consulting Group (BCG) AI Science Institute and is… Read More
A team at Standford have created CRISPR-GPT, a large language model (LLM) agent system to automate and enhance CRISPR-based gene-editing design and data analysis. CRISPR-GPT leverages the reasoning capabilities of LLMs for complex task decomposition, decision-making and interactive human–artificial intelligence (AI) collaboration. The system incorporates… Read More
SandboxAQ today announced a round of more than $300 million, which valued the company at $5.3 billion on a pre-money basis. The money came from investors Fred Alger Management, T Rowe Price Associates, Mumtalakat, Parkway Venture Capital, Breyer Capital, Rizvi Traverse, S32, US Innovative Technology Fund,… Read More
Dr Mutlu Dogruel, Vice President of AI Solutions at Cresset, examines AI’s transformative potential, highlights the current challenges and introduces a series of potential solutions to implement AI in the drug discovery landscape successfully. The use of artificial intelligence (AI) is creating a paradigm shift in… Read More
DDW Editor Reece Armstrong speaks to Jouhyun Jeon, Principal Investigator at Klick Applied Sciences, about the company’s artificial intelligence algorithm, LOVENet, and how it offers a fresh perspective for repurposed drugs. RA: First off, could you tell me about the LOVENet algorithm? … Read More
